- Home
- OCGN vs NPCT Comparison
OCGN vs NPCT Comparison
Compare OCGN & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- NPCT
- Stock Information
- Founded
- OCGN 2013
- NPCT 2020
- Country
- OCGN United States
- NPCT United States
- Employees
- OCGN N/A
- NPCT N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- NPCT Investment Managers
- Sector
- OCGN Health Care
- NPCT Finance
- Exchange
- OCGN Nasdaq
- NPCT Nasdaq
- Market Cap
- OCGN 283.3M
- NPCT 314.6M
- IPO Year
- OCGN N/A
- NPCT N/A
- Fundamental
- Price
- OCGN $1.05
- NPCT $10.96
- Analyst Decision
- OCGN Strong Buy
- NPCT
- Analyst Count
- OCGN 3
- NPCT 0
- Target Price
- OCGN $6.00
- NPCT N/A
- AVG Volume (30 Days)
- OCGN 2.6M
- NPCT 107.1K
- Earning Date
- OCGN 08-01-2025
- NPCT 01-01-0001
- Dividend Yield
- OCGN N/A
- NPCT 9.82%
- EPS Growth
- OCGN N/A
- NPCT N/A
- EPS
- OCGN N/A
- NPCT N/A
- Revenue
- OCGN $4,754,000.00
- NPCT N/A
- Revenue This Year
- OCGN N/A
- NPCT N/A
- Revenue Next Year
- OCGN N/A
- NPCT N/A
- P/E Ratio
- OCGN N/A
- NPCT N/A
- Revenue Growth
- OCGN N/A
- NPCT N/A
- 52 Week Low
- OCGN $0.52
- NPCT $8.58
- 52 Week High
- OCGN $1.40
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- OCGN 53.85
- NPCT 50.82
- Support Level
- OCGN $1.01
- NPCT $10.88
- Resistance Level
- OCGN $1.07
- NPCT $11.05
- Average True Range (ATR)
- OCGN 0.05
- NPCT 0.10
- MACD
- OCGN 0.00
- NPCT 0.00
- Stochastic Oscillator
- OCGN 66.48
- NPCT 60.06
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.